What is your approach to CMML-MDS in an older patient with low risk disease who is becoming transfusion dependent?
Would you use a trial of dexamethasone for a patient with thrombocytopenia?
1 Answer
Mednet MemberInvited Expert
Medical Oncology · UC San Diego Health
Answered on
The short answer is that we treat lower risk CMML much like we treat lower risk MDS, even though we don't have dedicated studies in CMML to support this approach. After addressing any reversible causes of anemia (iron or vitamin deficiencies, hemolysis, etc...), NCCN guidelines for MDS would recomme...
Join for free or sign in to see the full answer